The Center for Public Integrity
Home
About the Center
ICIJ
Donate
Investigations by email
Politics
Accountability
Health
Environment
National Security
Juvenile Justice
Pharmaceuticals policy - news and investigations
Analysis — Are seniors paying attention to Paul Ryan's plan for Medicare?
By
Wendell Potter
April 18, 2011
ANALYSIS: Republicans sold seniors a bill of goods on health care reform and Medicare
Related to this story
OPINION: Guess who would benefit from privatizing Medicare?
By
Wendell Potter
June 4, 2012
Medicare patients received expired, terminated drugs
By
Joe Eaton
November 4, 2010
GAO: Almost a tenth of Medicare spending was improper
By
Laurel Adams
March 3, 2011
Report faults Medicare controls on widely abused drugs
By
Joe Eaton
October 4, 2011
GAO: Almost a tenth of Medicare spending was improper
By
Laurel Adams
March 3, 2011
An estimated $48 billion went to improper Medicare payments last year, out of the $509 billion spent on health care for elderly and disabled
Related to this story
Analysis — Are seniors paying attention to Paul Ryan's plan for Medicare?
By
Wendell Potter
April 18, 2011
Report faults Medicare controls on widely abused drugs
By
Joe Eaton
October 4, 2011
OPINION: Guess who would benefit from privatizing Medicare?
By
Wendell Potter
June 4, 2012
Medicare patients received expired, terminated drugs
By
Joe Eaton
November 4, 2010
Medicare can’t identify top prescribers of addictive drugs
By
The Center for Public Integrity
and
Joe Eaton
February 8, 2011
Medicare doesn't know if all the prescriptions it is paying for are being written by real doctors, says a new inspector general's report....
Related to this story
States see importation as solution to high drug costs
By
Victoria Kreha
April 6, 2006
Spending on lobbying thrives
By
M. Asif Ismail
April 1, 2007
A record year for the pharmaceutical lobby in '07
By
M. Asif Ismail
June 24, 2008
Senator seeks deadline for Medicare to prevent prescription drug fraud
By
Joe Eaton
August 5, 2010
Advertisement
Senator seeks deadline for Medicare to prevent prescription drug fraud
By
Joe Eaton
August 5, 2010
Taxpayer-funded Medicare recently spent more than $1 billion on drug prescriptions missing a valid doctor identification number and a Senate
Related to this story
Prescription for power
By
M. Asif Ismail
April 28, 2005
OPINION: Rep. Ryan's budget plan is a "Path to the Poorhouse"
By
Wendell Potter
August 11, 2012
OPINION: Big Pharma's stranglehold on Washington
By
Wendell Potter
February 11, 2013
Health information technology: Incentives may not always serve intended purpose
By
Josh Israel
and
Kimberly Leonard
October 12, 2011
Congressman takes swipe at program to reduce Medicare fraud
By
Naseem Miller
and
Joe Eaton
November 19, 2009
As health reform bills consume Congress, a battle over a program designed to help cut soaring rates of Medicare overpayment and fraud is pla
Related to this story
OPINION: Rep. Ryan's budget plan is a "Path to the Poorhouse"
By
Wendell Potter
August 11, 2012
FACT CHECK: Democrats' repeat ‘end Medicare’ cry is wrong, again
By
FactCheck.Org
March 6, 2012
Study: Medicare contractors vulnerable to conflict
By
The Associated Press
July 10, 2012
Medicare fraud out of control
By
The Center for Public Integrity
December 10, 2008
Medicare patients received expired, terminated drugs
By
Joe Eaton
November 4, 2010
Medicare patients in 2006-07 likely received more than $112 million worth of expired prescription drugs or drugs that have been pulled from
Related to this story
Analysis — Are seniors paying attention to Paul Ryan's plan for Medicare?
By
Wendell Potter
April 18, 2011
Report faults Medicare controls on widely abused drugs
By
Joe Eaton
October 4, 2011
OPINION: Guess who would benefit from privatizing Medicare?
By
Wendell Potter
June 4, 2012
GAO: Almost a tenth of Medicare spending was improper
By
Laurel Adams
March 3, 2011
Advertisement
Health reform lobbyist mistakenly errs on side of transparency
By
Joe Eaton
March 15, 2010
If numbers are to be trusted, longtime advertising lobbyist Jim Davidson of Polsinelli Shughart is the top dog of the 2009 health care refor
Related to this story
Commentary: Changing Washington: The hard part
By
Bill Buzenberg
March 24, 2009
PhRMA's envoys
By
M. Asif Ismail
January 18, 2005
Drug lobby second to none
By
M. Asif Ismail
July 7, 2005
Spending on lobbying thrives
By
M. Asif Ismail
April 1, 2007
More big money from pharmaceutical lobby in 2008
By
Mary Beth Lombardo
July 11, 2008
The economy may be sliding, but that hasn’t stemmed the high-rolling habits of Washington’s largest lobby. In 2007, as the Center recently r
Related to this story
Surrogates for their agenda
By
Alexander Cohen
July 7, 2005
Deep pockets contribute to success
By
M. Asif Ismail
April 6, 2006
Checkbook politics
By
Victoria Kreha
July 7, 2005
Drug makers' dime funds Congressional travel
By
Robert Brodsky
August 30, 2006
Commentary: Changing Washington: The hard part
By
Bill Buzenberg
March 24, 2009
The difficulty overcoming the entrenched political tradition of earmarks is just one of many hard realities that will test the Obama Adminis
Related to this story
Health reform lobbyist mistakenly errs on side of transparency
By
Joe Eaton
March 15, 2010
Drug lobby second to none
By
M. Asif Ismail
July 7, 2005
Checkbook politics
By
Victoria Kreha
July 7, 2005
PhRMA's envoys
By
M. Asif Ismail
January 18, 2005
FDA reaches agreement with firm that produced troubled heart drug
The U.S. Food and Drug Administration last week announced a little-noticed tentative agreement setting conditions under which a troubled pha
Related to this story
Drug makers' dime funds Congressional travel
By
Robert Brodsky
August 30, 2006
Deep pockets contribute to success
By
M. Asif Ismail
April 6, 2006
Surrogates for their agenda
By
Alexander Cohen
July 7, 2005
More big money from pharmaceutical lobby in 2008
By
Mary Beth Lombardo
July 11, 2008
Pages
1
2
3
4
next ›
last »
Powered by
Calais